Health & Women
Food and Drug Administration approves a new treatment for advanced breast cancer linked to a genetic mutation
The Saudi Food and Drug Authority has approved the registration of Etkamah preparation “Kamizstrant” for the treatment of adult patients with locally advanced or metastatic breast cancer of the hormone receptor-positive type,…
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
